Helsinn

Views & Analysis

Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three generations.

News

Neurocrine Biosciences has agreed a $2.9bn deal to buy Soleno Therapeutics and its treatment for a rare, genetic form of severe obesity.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.